Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line

doi:10.3748/wjg.v18.i40.5669

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5977)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

557

HTML

4897

Figures (1-2)

279

Tables (1-2)

244

Sum=5977

Oct 28, 2012 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (48)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines For Clinical Practice

World J Gastroenterol. Oct 28, 2012; 18(40): 5669-5678
Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5669

Full Size Figure Download Figure

Figure 2 Meta-analysis comparing the incidence of side effects with levofloxacin/amoxicillin-based triple therapy vs quadruple therapy for Helicobacter pylori eradication. CI: Confidence interval; LA: Levofloxacin/amoxicillin.

Citation: Caro SD, Fini L, Daoud Y, Grizzi F, Gasbarrini A, Lorenzo AD, Renzo LD, McCartney S, Bloom S. Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line. World J Gastroenterol 2012; 18(40): 5669-5678
URL: https://www.wjgnet.com/1007-9327/full/v18/i40/5669.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i40.5669